We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.24B
AUM Growth
-$107M
(-4.6%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-6.17%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
955
New
308
Increased
134
Reduced
160
Closed
350
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.3M |
| 2 |
Merck
MRK
|
+$28.9M |
| 3 |
Morgan Stanley
MS
|
+$28.2M |
| 4 |
Verizon
VZ
|
+$27.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$22.4M |
| 2 |
Duke Energy
DUK
|
+$22M |
| 3 |
Cognizant
CTSH
|
+$19.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$19M |
| 5 |
Eaton
ETN
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.11% |
| 2 | Healthcare | 14.85% |
| 3 | Industrials | 13.1% |
| 4 | Technology | 12.1% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Ralph Lauren
RL
$22.6B
| $1.49M | 0.07% |
13,085
-6,457
| -33% | -$774K |
|
302
Match Group
MTCH
$9.05B
| $1.48M | 0.07% |
+22,044
| New | +$1.44M |
|
|
STL
303
DELISTED
Sterling Bancorp
STL
| $1.45M | 0.06% |
+68,022
| New | +$1.4M |
|
|
LEXEA
304
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $1.44M | 0.06% |
+30,204
| New | +$1.33M |
|
305
Howmet Aerospace
HWM
$115B
| $1.44M | 0.06% |
+72,564
| New | +$1.22M |
|
306
Oshkosh
OSK
$9.66B
| $1.44M | 0.06% |
+17,203
| New | +$1.35M |
|
307
AES
AES
$10.6B
| $1.43M | 0.06% |
+85,367
| New | +$1.45M |
|
308
Watsco Inc
WSO
$15B
| $1.43M | 0.06% |
8,725
-3,655
| -30% | -$574K |
|
309
CMS Energy
CMS
$22.9B
| $1.43M | 0.06% |
24,619
-58,264
| -70% | -$3.27M |
|
310
Associated Banc-Corp
ASB
$5.78B
| $1.42M | 0.06% |
+67,080
| New | +$1.46M |
|
311
Steris
STE
$21.3B
| $1.41M | 0.06% |
+9,493
| New | +$1.27M |
|
312
Canadian Pacific Kansas City
CP
$81.1B
| $1.4M | 0.06% |
29,690
-30,350
| -51% | -$1.36M |
|
313
StoneCo
STNE
$2.65B
| $1.39M | 0.06% |
46,985
+31,453
| +203% | +$925K |
|
|
FITB
314
Fifth Third Bancorp
FITB
$51.7B
| $1.38M | 0.06% |
49,581
-77,185
| -61% | -$2.12M |
|
315
COPT Defense Properties
CDP
$4.34B
| $1.38M | 0.06% |
+52,175
| New | +$1.46M |
|
|
HOLX
316
DELISTED
Hologic
HOLX
| $1.37M | 0.06% |
+28,594
| New | +$1.32M |
|
317
Teck Resources
TECK
$29.3B
| $1.37M | 0.06% |
+59,306
| New | +$1.33M |
|
318
O-I Glass
OI
$1.41B
| $1.37M | 0.06% |
79,104
+9,518
| +14% | +$170K |
|
319
Werner Enterprises
WERN
$2.42B
| $1.37M | 0.06% |
43,958
-5,094
| -10% | -$164K |
|
320
MGIC Investment
MTG
$6.34B
| $1.36M | 0.06% |
+103,425
| New | +$1.44M |
|
321
Carlisle Companies
CSL
$13.8B
| $1.35M | 0.06% |
9,622
-11,408
| -54% | -$1.53M |
|
322
Stellantis
STLA
$16.5B
| $1.33M | 0.06% |
+96,159
| New | +$1.4M |
|
|
SVC
323
Service Properties Trust
SVC
$1.08B
| $1.32M | 0.06% |
+10,579
| New | +$1.36M |
|
|
STOR
324
DELISTED
STORE Capital Corporation
STOR
| $1.3M | 0.06% |
39,223
-17,110
| -30% | -$578K |
|
|
AQ
325
DELISTED
Aquantia Corp. Common Stock
AQ
| $1.3M | 0.06% |
+99,870
| New | +$1.17M |
|
Similar funds
CCA
HPIA
GAMA
TWP
ACA
CAAM
RK
PCM
Stevens Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stevens Capital Management held 955 positions worth $2.24B, down 4.6% from $2.34B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Stevens Capital Management withdrew a net $138M in Q2 2019, closing 350 positions and reducing 160 holdings. Its most notable exit was Cognizant, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in Merck worth $30.2M.
- Stevens Capital Management's largest Q2 2019 buy was Merck: 377,581 shares worth $30.2M.
- Stevens Capital Management added most to Eli Lilly in Q2 2019, an estimated $31.3M increase.
- Stevens Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $22.4M.
- Stevens Capital Management fully exited Cognizant in Q2 2019, selling an estimated $19.2M.
- Stevens Capital Management's ten largest holdings make up 13% of its $2.24B portfolio in Q2 2019.
- Stevens Capital Management opened 308 new positions and closed 350 in Q2 2019.
- Stevens Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.24B.
Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.